Noopept (Russian: Ноопепт; GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester) is a peptide promoted and prescribed in Russia and neighbouring countries as a nootropic. The registered brand name Noopept (Ноопепт) is trademarked by the manufacturer JSC LEKKO Pharmaceuticals. The compound is patented in both the US and Russia with patent of Russian Federation number 2119496, U.S. Patent 5,439,930 issued 8/8/1995. It is sold as a dietary supplement in the US and as a medication in other countries.[which?]

CAS：157115-85-0
中文别名：苯乙酰甘氨酸乙酯;
英文别名：ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate;
分子式：C17H22N2O4
分子量：318.368
精确质量：318.158
Psa：75.71
Logp：1.2282

UNII：4QBJ98683M

密度：1.202g/cm3
沸点：547.3ºC at 760mmHg
闪点：284.8ºC
折射率：1.548
蒸汽压：4.93E-12mmHg at 25°C

海关编码：2942000000

用途
用于医药中间体及保健品添加剂，可以提高大脑记忆的功。